Watch FIFA World Cup 2026™

LIVE, FREE and EXCLUSIVE

Treating COVID-19 with Paxlovid. What are the pros and cons?

A Pfizer lab technician visually inspects Paxlovid tablet samples in Freiburg, Germany (Suppled - Pfizer).

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus. But since its approval, there have been questions about why it takes so long to make Paxlovic.


Published

Updated

By Ricky Kusumo, Tina Quinn

Presented by sri dean

Source: SBS




Share this with family and friends


Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus. But since its approval, there have been questions about why it takes so long to make Paxlovic.


While the time frame to make the pill isn't unusual, some people are wondering if and when supplies will improve.  How does this impact on those vulnerable to COVID-19?

Listen to SBS Indonesian every Monday, Wednesday, Friday and Sunday at 3 pm. Follow us on Facebook and catch us on podcasts.

And you can keep abreast of the latest information about the corona virus in your language at sbs.com.au/coronavirus


Latest podcast episodes

Follow SBS Indonesian

Download our apps

Listen to our podcasts

Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS

SBS Indonesian News

Watch it onDemand

Watch now